Heppeler A - Search Results

1

Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy.

Froidevaux S, Heppeler A, Eberle AN, Meier AM, Häusler M, Beglinger C, Béhé M, Powell P, Mäcke HR. Froidevaux S, et al. Among authors: heppeler a. Endocrinology. 2000 Sep;141(9):3304-12. doi: 10.1210/endo.141.9.7683. Endocrinology. 2000. PMID: 10965902

2

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model.

Froidevaux S, Eberle AN, Christe M, Sumanovski L, Heppeler A, Schmitt JS, Eisenwiener K, Beglinger C, Mäcke HR. Froidevaux S, et al. Among authors: heppeler a. Int J Cancer. 2002 Apr 20;98(6):930-7. doi: 10.1002/ijc.10295. Int J Cancer. 2002. PMID: 11948475

3

DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.

Otte A, Jermann E, Behe M, Goetze M, Bucher HC, Roser HW, Heppeler A, Mueller-Brand J, Maecke HR. Otte A, et al. Among authors: heppeler a. Eur J Nucl Med. 1997 Jul;24(7):792-5. doi: 10.1007/BF00879669. Eur J Nucl Med. 1997. PMID: 9211767

4

Yttrium-90 DOTATOC: first clinical results.

Otte A, Herrmann R, Heppeler A, Behe M, Jermann E, Powell P, Maecke HR, Muller J. Otte A, et al. Among authors: heppeler a. Eur J Nucl Med. 1999 Nov;26(11):1439-47. Eur J Nucl Med. 1999. PMID: 10552085

5

Receptor targeting for tumor localisation and therapy with radiopeptides.

Heppeler A, Froidevaux S, Eberle AN, Maecke HR. Heppeler A, et al. Curr Med Chem. 2000 Sep;7(9):971-94. doi: 10.2174/0929867003374516. Curr Med Chem. 2000. PMID: 10911025 Review.

6

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.

Reubi JC, Schär JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Mäcke HR. Reubi JC, et al. Among authors: heppeler a. Eur J Nucl Med. 2000 Mar;27(3):273-82. doi: 10.1007/s002590050034. Eur J Nucl Med. 2000. PMID: 10774879

7

Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting.

Heppeler A, André JP, Buschmann I, Wang X, Reubi JC, Hennig M, Kaden TA, Maecke HR. Heppeler A, et al. Chemistry. 2008;14(10):3026-34. doi: 10.1002/chem.200701264. Chemistry. 2008. PMID: 18246556

8

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.

Hofmann M, Maecke H, Börner R, Weckesser E, Schöffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H. Hofmann M, et al. Among authors: heppeler a. Eur J Nucl Med. 2001 Dec;28(12):1751-7. doi: 10.1007/s002590100639. Epub 2001 Oct 31. Eur J Nucl Med. 2001. PMID: 11734911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters